Subscribe Now

* You will receive the latest news and updates on your favorite celebrities!

Trending News

Blog Post

New communication between science and business drives growth in both fields
Business

New communication between science and business drives growth in both fields 

The COVID-19 pandemic has caused disruption in many fields, business drives growth and scientific research is the subject. To public scrutiny on a new scale. The public is hungry for information, and businesses directly. Impacted by the consequences of the pandemic are hungry to know more so they can create strategic action plans. Historically, however, the relay of information and findings from scientists has been a fast-paced performance.

Now that the scientific audience has grown to include the general public (thanks to COVID-19), the supply and demand for this information are growing as well.

New interactions between leaders in the scientific community and those in the business community are setting new precedents, albeit with challenges for both.

Risk of what is lost in translation

Communicating evolving scientific information to the public is inherently challenging and risky. While scientists appreciate that each data point and conclusion has specific context and nuance. The public may not be equipped to do the same. Furthermore, careful, meticulous scientific studies often follow timelines that cannot be accelerated, yet the public is still clamoring to know more. Early information sharing leads to confusion.

Furthermore, the advent of social media as a platform for widely sharing information has its pros and cons.

We spoke with a scientist and founder of two investor-backed antivirus companies.

Novira Therapeutics and Orthogon Therapeutics, Dr. Ali H. Munawar. He is pioneering a new class of drugs that target viral proteins that are often intolerant of conventional drug discovery approaches. He leads a team of scientists who have made remarkable strides in antiviral therapy including. The discoveries of COVID-19 related to the SARS-CoV-2 Orf9b atomic structure. Development of pan-coronavirus therapeutics and mechanism of action studies around the purported COVID-19 benefits of famotidine. In addition to overseeing research and development, he is also a successful business leader raising over $50 million. In investments for his companies from venture capital funds and angel groups. . Communicating scientific discoveries, insights, and principles to non-scientists, investors and the general public is a task. He faces on a regular basis. For both sides, as it were, his point of view is an important one.

 

Munawar explains that the public’s growing thirst for scientific knowledge is a positive thing. However, the dissemination of scientific information, and its rapid spread through social media and other publicly accessible platforms, present a number of risks of its own.

The first risk is a misinterpretation.

To people who have a correct basic understanding of scientific methods and processes.

The second risk is bias and abuse. Without a doubt, there are political organizations and entities that post, repost, and edit about scientific communication, leading people along a certain model path that meets a particular agenda.

The third risk is a lack of quality control. Scientific research goes through a process of peer review and screening based on reviewers’ questions, concerns, and feedback before it is considered worthy of publication. This proofreading process ensures that the findings are reliable, scientifically sound. 

Disseminating information too soon to the unscientific and forwarded public without proper scientific context can lead to ineffective or even politicized policies.

The power of perception is accelerated

The COVID-19 pandemic has created unprecedented awareness of the biological product cycle, especially in non-scientific fields. Record total investment in biopharma companies‘ business drives growth has helped raise respect for science and research.  This renewed concern creates an environment in which any influential leader must exercise self-education methods. To avoid the risks outlined above and secure a bright future. brighter

Onus are leaders who must educate themselves and adjust as necessary

Leaders in any field have the opportunity to shape the message and adoption of new ideas among their followers. Depending on the size of an organization, leaders can do different things to educate themselves and inform their team.

Munawar has direct experience in this regard, advising that large companies can afford it. To have a healthcare or scientific analysis unit that can analyze, synthesize and communicate relevant conclusions in a timely manner. A scientific way for leader and team. When appropriately qualified individuals and backgrounds are operating as exceptional translators, the risk of abuse or misunderstanding is reduced. Smaller companies may not have the effective resources to communicate such information effectively.

Regardless of whether such comprehensive resources exist or not, leaders.

Companies of any size and in any field can work towards. A better understanding of the principles and scientific methodology. Munawar emphasizes, “Interacting with scientists and holding scientific conferences is one way of following the scientific process. Knowledge of fairness and minimizing business drives growth bias is an integral part of the process. the science that the public must understand.”

Most of us are now aware that algorithms serve us relevant information online. A process that often leads to ideologically inclined thinking or exposure to nuanced information. Leaders at the forefront of development in any field will understand. The risks of not fully understanding how scientific research works, being able. To thoroughly analyze the content they are reading. exposure and encourage their people to do the same.

 

Related posts

Leave a Reply

Required fields are marked *